Amneal Pharmaceuticals (AMRX) Receivables - Other (2017 - 2026)
Amneal Pharmaceuticals (AMRX) recorded Receivables - Other of $9.44 million in Q3 2026, down 36.4% from $14.84 million a year earlier but up 105.1% from the prior quarter.
Amneal Pharmaceuticals (AMRX) Receivables - Other (2017 - 2026) Analysis & Trends
At the end of FY2025, Amneal Pharmaceuticals reported Receivables - Other of $5.3 million, up 18.6% from FY2024.
- Annual Receivables - Other has a five-year compound annual growth rate of -20.9% (FY2020 to FY2025).
- Across earlier years, Receivables - Other came in at $4.47 million in FY2024 (-55.0%), $9.93 million in FY2023 (-70.0%), $33.13 million in FY2022 (+239.1%) and $9.77 million in FY2021 (-42.9%).
- Quarterly Receivables - Other has ranged from $100,000 in Q4 2021 to $47.21 million in Q1 2022 over the past five years.
- On a year-over-year basis, Receivables - Other has declined for three consecutive quarters, with growth averaging 5.2% over the last eight quarters.
- Peak year-over-year performance for Receivables - Other in the last five years was growth of 107.1% in Q2 2025, against a decline of 90.0% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.6 million (Q2 2026), $6.17 million (Q1 2026) and $5.3 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,300.96 Bn | 1,274.58 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 691.57 Bn | 611.43 Bn | 17.30 Bn |
| 3 | AbbVie | 526.86 Bn | 494.87 Bn | 13.12 Bn |
| 4 | Merck | 365.17 Bn | 328.11 Bn | 13.19 Bn |
| 5 | Novartis Ag | 314.51 Bn | 287.74 Bn | - |
| 6 | Astrazeneca | 288.94 Bn | 262.45 Bn | 13.26 Bn |
| 7 | Amgen | 254.33 Bn | 205.98 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 211.53 Bn | 186.64 Bn | 6.73 Bn |
| 9 | Pfizer | 166.13 Bn | 113.48 Bn | 12.56 Bn |
| 10 | Amneal Pharmaceuticals | 7.17 Bn | 6.41 Bn | 334.12 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 9.44 Mn |
| Jun 30, 2026 | 4.60 Mn |
| Mar 31, 2026 | 6.17 Mn |
| Dec 31, 2025 | 5.30 Mn |
| Sep 30, 2025 | 14.84 Mn |
| Jun 30, 2025 | 16.33 Mn |
| Mar 31, 2025 | 20.51 Mn |
| Dec 31, 2024 | 4.47 Mn |
| Sep 30, 2024 | 7.86 Mn |
| Jun 30, 2024 | 7.89 Mn |
| Mar 31, 2024 | 12.80 Mn |
| Dec 31, 2023 | 9.93 Mn |
| Sep 30, 2023 | 15.11 Mn |
| Jun 30, 2023 | 14.47 Mn |
| Mar 31, 2023 | 14.02 Mn |
| Dec 31, 2022 | 33.13 Mn |
| Sep 30, 2022 | 9.37 Mn |
| Jun 30, 2022 | 17.75 Mn |
| Mar 31, 2022 | 47.21 Mn |
| Dec 31, 2021 | 100,000.00 |
Amneal Pharmaceuticals Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=AMRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();